Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
40 participants
INTERVENTIONAL
2022-03-10
2023-03-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Excimer Laser Phototherapy Outcomes in the Treatment of Psoriasis
NCT02294981
Efficacy of Pulsed High Intensity Laser Therapy in Psoriatic Hand Arthritis
NCT06665282
Excimer Laser, Serum Markers & Psoriasis
NCT02165657
Methotrexate Alone vs Combination With Excimer Light in Nail Psoriasis
NCT06150794
Excimer Laser With Topical Agents in Psoriasis Vulgaris
NCT05555797
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Active psoriasis
Excimer light
Excimer light sessions
Stable psoriasis
Excimer light
Excimer light sessions
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Excimer light
Excimer light sessions
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Less than 10% surface area.
Exclusion Criteria
* Pustular psoriasis
* Topical treatment for psoriasis for the past 2 weeks.
* Systemic retinoids in the last 2 years.
* Systemic treatments (including any drugs that affect SP level as Aprepitant) in the last 3 months.
* Contraindications to excimer light therapy (history of skin malignancy or precancerous conditions like xeroderma pigmentosum or photosensitivity)
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Cairo University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Marwa Salah El-Din El-Mesidy
Dr.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Kasr Al Ainy Faculty of medicine
Cairo, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Excimer light in psoriasis
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.